New York, May 29, 2026, 06:02 EDT
- FG Imperii shares were last at $9.92, up 2 cents. Its warrants last traded at $0.2008.
- The company reported $229.0 million in its trust account as of March 31. It had not posted any operating revenue.
- New deals are hitting the wider SPAC market again, with ProLogium announcing a $3.8 billion agreement with Translational Development Acquisition Corp this week.
Shares of FG Imperii Acquisition Corp edged up 2 cents to $9.92 in premarket Nasdaq quotes on Friday. The blank-check firm hovered just under $10, a typical area for SPACs, as investors looked for signs of a deal.
FG Imperii is mostly just a cash shell at this point. The company is a SPAC, or special purpose acquisition company, which means it trades as an empty vehicle that raises funds to buy a private firm and bring it to market outside of a standard IPO.
The stock is mostly tied to its redemption value and how the market sees SPAC deals, not sales or profit. FG Imperii said in its last quarterly report that it hasn’t started operations and does not expect to see any operating revenue until it finishes a business combination.
Stock futures traded flat early Friday with Wall Street indexes at highs. Daniela Hathorn, a senior market analyst at Capital.com, said to Reuters “risk appetite has improved,” but warned that “valuations are elevated.” Reuters
FG Imperii’s March-quarter filing listed $229.0 million in its trust account for public shareholder redemptions, with $897,989 of cash held outside the trust. Net income for the quarter was $1.4 million, as $1.55 million in trust investment income was partially offset by $149,875 in general and administrative costs.
FG Imperii set its IPO price at $10 per unit back in January. Each unit includes a Class A ordinary share and half a redeemable warrant. The warrants let holders buy more shares later for $11.50.
FG Imperii brought in $227.5 million in gross proceeds after the underwriter took a partial over-allotment. Its ordinary shares and warrants started trading separately on Nasdaq in March, listed as FGII and FGIIW. The unseparated units kept trading under FGIIU.
Blank-check deals are still on the table. ProLogium, a battery maker from Taiwan, said on May 27 that it plans to go public on Nasdaq by merging with Translational Development Acquisition Corp in a $3.8 billion SPAC deal. That’s a bigger and later-stage move than what FG Imperii is looking for, but it gives some sense of where the market is now.
FG Imperii plans to search for deals mainly in North American financial-services firms, but hasn’t ruled out other sectors. The company has 24 months after its IPO closes to finish a business combination, according to its filing.
But there’s a real risk here. FG Imperii has to wrap up a deal before time runs out or it will have to return money to public shareholders and dissolve, which would kill the warrants. A rough target, lots of redemptions, or a slow IPO market could keep the shares stuck near cash value instead of moving up on hopes for growth.
Right now, it’s about price, not earnings. The clock is ticking, and what happens next will depend on whether trust holds up and if FG Imperii lands a deal investors actually want.
